Navigation Links
KaloBios Announces Retirement Of Chief Financial Officer
Date:8/5/2013

SOUTH SAN FRANCISCO, Calif., Aug. 5, 2013 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the retirement of Jeffrey H. Cooper, the company's Chief Financial Officer, effective as of December 31, 2013.  Mr. Cooper has decided to retire in order to dedicate more time to family and personal interests. Mr. Cooper has committed to stay at the company in a full-time role until mid-November, and as a part-time advisor until the end of the calendar year, and will assist the company in locating and transitioning to a successor.

(Logo: http://photos.prnewswire.com/prnh/20130225/MM66380LOGO)

"Jeff has made outstanding contributions to KaloBios in our initial public offering and finance and accounting management," said David Pritchard, President and Chief Executive Officer of KaloBios. "We regret Jeff's decision to retire, but appreciate his desire to work with KaloBios to ensure a smooth transition by the end of the year."

"I am fortunate to be able to retire and spend more time with my family and renew my focus on my personal activities," Mr. Cooper commented. "My decision in no way reflects upon the bright future for KaloBios, its pipeline of clinical programs and its outstanding management team, whom I have enjoyed working with over the past year. I look forward to working with the team during the transition process in the coming months."

Mr. Cooper joined KaloBios in July 2012 as Chief Financial Officer. He was previously Senior Vice President and Chief Financial Officer of BioMarin Pharmaceutical, Inc., a publicly traded pharmaceutical company. At BioMarin, Mr. Cooper started in 2003 as Vice President, Controller, and then served as its Chief Financial Officer from 2005 to Ma
'/>"/>

SOURCE KaloBios Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. KaloBios Appoints Donald R. Joseph as Chief Legal Officer
2. U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur and KaloBios Novel Biologic Candidate for Pseudomonas aeruginosa
3. KaloBios Announces Fiscal Year 2012 Financial Results
4. Natural Acne Treatment, Probiotic Action Announces Their Topical Probiotic Is Safe for Sun Exposure
5. Sorrento Therapeutics Announces Reverse Split of Common Stock
6. SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER FINANCIAL RESULTS
7. Visiting Nurse Association of Northern New Jersey Announces Gardening Program at Friendship House Adult Day Care
8. Metabolix Announces Second Quarter 2013 Financial Results
9. Life Technologies Announces Second Quarter 2013 Results
10. BioAstrum Announces New Transfection Tools Market Report
11. MiMedx Announces Record Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Calif. (PRWEB) January 15, 2014 Cynvenio, ... and management through the genomic analysis of tumor cells ... Therapy Finder™, a web-based cancer decision support application powered ... option with Cynvenio’s ClearID™ genomic test, Therapy Finder will ...
(Date:1/15/2014)... More than 5 million Americans are currently living ... will die with Alzheimer’s or another dementia, according to ... many Americans into looking for ways to improve their ... cognitive disorders. Jonathan Weisman, president of Biohack Pure, is ...
(Date:1/15/2014)... 15, 2014 Freeslate, Inc ., ... announced that Lupin Limited, one of India’s top five ... Protégé PharmD System for high throughput solid form ... focused on a wide range of quality, affordable generic ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company developing ... simulated embryonic conditions, today announced that they have entered ... for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent cell ... an amendment to the existing license between Histogen and ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... Danaher Corporation (NYSE:,DHR) announced that President and Chief ... at the J.P. Morgan Healthcare Conference in,San Francisco ... The audio will be,simultaneously webcast on http://www.danaher.com ... for one week., Danaher Corporation is ...
... THOR ), a world leader in products ... be participating in the JP,Morgan Healthcare Conference on ... chief executive officer, will provide an,update on the ... (11:30,a.m., Eastern Standard Time)., The presentation will ...
... than 500,000 Total Prescriptions Have Been Dispensed for ... ... 3 Shire plc (LSE: SHP,Nasdaq: SHPGY, TSX: SHQ), the ... from the U.S. Food and Drug,Administration (FDA) for three additional ...
Cached Biology Technology:FDA Approves Additional Dosage Strengths of Shire's ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients 2FDA Approves Additional Dosage Strengths of Shire's ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients 3FDA Approves Additional Dosage Strengths of Shire's ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients 4FDA Approves Additional Dosage Strengths of Shire's ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients 5
(Date:7/9/2014)... of increasing concern about the prevalence of antibiotic-resistant ... promising new pathway to disabling disease: blocking bacteria,s ... scientists showed how bacterial siderophore, a small molecule, ... fan bacterial growth as well as how ... infection process. Their findings appear in a recent ...
(Date:7/9/2014)... and fever but often can be defeated with antibiotics ... to beat. Now, scientists have built a new weapon against ... in the journal ACS Applied Materials & Interfaces , ... more of them than medicine alone. , David Leong, Jianping ... in wait, undetectable in the human body or in places ...
(Date:7/9/2014)... the amphibians with the highest distribution in the Iberian ... where it comes into contact with the red swamp ... by the Spaniard Germn Orizaola from the University of ... have developed a defensive response to the invasive species. ... they co-exist with the crayfish. , Numerous invasive organisms ...
Breaking Biology News(10 mins):Bacteria hijack plentiful iron supply source to flourish 2Frogs have developed rapid defences against the red swamp crayfish 2Frogs have developed rapid defences against the red swamp crayfish 3
... COLUMBIA, MO The American Association for the Advancement ... to Arun Chatterjee, a professor emeritus of plant sciences ... at the University of Missouri. Chatterjee was ... plant bacteriology, particularly for global regulation of virulence factors ...
... that the impact of disease-resistant genetically-modified wheat plants ... have looked at the effects of genetically-modified (GM) ... characterised by numerous insect species forming food webs. ... transgenic disease-resistant wheat lines and their effect on ...
... Madison, WI JANUARY 20, 2011 -- Chronic ... municipal wastewater, and atmospheric deposition from the burning of ... and harmful algal blooms. This nutrient pollution is prevalent ... Bay is the largest estuary in North America and ...
Cached Biology News:University of Missouri professor elected to American Association for the Advancement of Science 2New Anglo-Swiss research questions impact of GM wheat on insects 2Could oysters be used to clean up Chesapeake Bay? 2
SDS-OutT SDS Precipitation Reagent...
... for fully automated systems for a broad ... configured for applications ranging from compound logistics, ... loop screening, which means it has fully ... picking and follow up studies all at ...
... Series of systems provide fast and reliable scalable automation ... development laboratories. Staccato systems are available in three base ... Series. ... All Staccato Application ...
Comp Dim: chamber L W D 45 45 0.8 mm chamber maximum volume 1500 μL...
Biology Products: